Verici DX (VRCI): Placing of 155% of the market value
This situation live
VRCI Verici DX
30 Sep 2026 · completed · +7% on the day · +0% until the next step
The 35 centres currently using Tutivia now represent 23% of annual kidney transplants in the US.
30 Sep 2026 · announced · +7% on the day · +0% until the next step
The Proposed Fundraise will enable the Company to maintain these growth plans.
8 Oct 2026 · announced · +0% on the day · +0% until the next step
Tutivia testing volumes have grown consistently, with a circa 52% increase in orders in Q3 2026 when compared with the same three-month period in 2025.
9 Oct 2026 · announced · +0% on the day · +0% until the next step
The Issue Price of the Retail Offer Shares is equal to the issue price in the Placing.
9 Oct 2026 · announced · +0% on the day · +0% until the next step
The Placing was increased to £8.5 million to accommodate additional interest received through the ABB, with strong support from both existing and new intuitional investors.
9 Oct 2026 · completed · +0% on the day · +0% until the next step
the Placing has now closed and the Bookbuild has been successfully concluded
13 Oct 2026 · completed · +0% on the day · +2% until the next step
the Company has raised £8.75 million through the Placing announced on 8 October 2026 and the WRAP Retail Offer launched on 9 October 2026
13 Oct 2026 · completed · +0% on the day · +2% until the next step
The Company has raised aggregate gross proceeds of approximately £250,000 pursuant to the Retail Offer, alongside the previously announced Placing.
30 Oct 2026 · completed · +0% since
The Company has raised total gross proceeds of £8.75m (net proceeds of £8.13m) through the Placing and WRAP Retail Offer.
Placing of 155% of the market value
completed
RaisePlacing · £8.0 million
Of market value155.4%
Discount11.1% to the last close
Use of the moneyworking capital
Reaction on the day+7%
As of 30 Oct 2026 ↗
Since Oct 2023: 306 situations of this kind – completed 77%, went quiet 23%; median share price -17% six months after they opened
Every step · 9
- 30 Sep 2026 completed · +7% on the day – The 35 centres currently using Tutivia now represent 23% of annual kidney transplants in the US. ↗
- 30 Sep 2026 announced · +7% on the day – The Proposed Fundraise will enable the Company to maintain these growth plans. ↗
- 8 Oct 2026 announced · +0% on the day – Tutivia testing volumes have grown consistently, with a circa 52% increase in orders in Q3 2026 when compared with the same three-month period in 2025. ↗
- 9 Oct 2026 announced · +0% on the day – The Issue Price of the Retail Offer Shares is equal to the issue price in the Placing. ↗
- 9 Oct 2026 announced · +0% on the day – The Placing was increased to £8.5 million to accommodate additional interest received through the ABB, with strong support from both existing and new... ↗
- 9 Oct 2026 completed · +0% on the day – the Placing has now closed and the Bookbuild has been successfully concluded ↗
- 13 Oct 2026 completed · +0% on the day – the Company has raised £8.75 million through the Placing announced on 8 October 2026 and the WRAP Retail Offer launched on 9 October 2026 ↗
- 13 Oct 2026 completed · +0% on the day – The Company has raised aggregate gross proceeds of approximately £250,000 pursuant to the Retail Offer, alongside the previously announced Placing. ↗
- 30 Oct 2026 completed – The Company has raised total gross proceeds of £8.75m (net proceeds of £8.13m) through the Placing and WRAP Retail Offer. ↗
What is happening
Verici DX: Placing of 155% of the market value – completed. ['completed']
- In short
- Verici DX is raising £8.0 million by placing, 155.4% of its market value, at a 11.1% discount; the shares moved +7% on the day.
- Announced
- 30 Sep 2026 · completed · +7% on the day
- Latest
- 30 Oct 2026 · completed · +7% on the day
Briefing Pro
New to Verici DX? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the VRCI briefing →From the company's own announcements. Not investment advice.
Also at Verici DX 2 open
OverhangHarwood Capital LLP selling down – 15.5217% → 8.611% in 5 notices
OverhangCANACCORD GENUITY GROUP INC selling down – 11.0216% → 3.969% in 3 notices
Upgrade / downgrade cycleResults below expectations – below expectations · second in 12 months · closed
Dilutive fundraisePlacing of 46% of the market value – completed · closed
Upgrade / downgrade cycleResults ahead of expectations – ahead of expectations · closed
Verici DX – company page →